Bioceres reports Q4 results

6 hours ago 1

Earnings News

Comments

Bioceres press release (NASDAQ:BIOX): Q4 net loss was $48.0 million and Adjusted EBITDA¹ was negative $4.5 million. For FY25, operating loss was $3.7 million, net loss was $55.2 million and Adjusted EBITDA¹ was $28.3 million.
Revenue of $74.7M (-39.8% Y/Y) misses by $35.38M.
Net cash flow generated by operating activities reached $29.9 million in 4Q25, and $53.0 million in FY25, a 27% YoY increase from FY24.

More on Bioceres

Recommended For You

More Trending News

Read Entire Article